207 related articles for article (PubMed ID: 22761942)
1. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.
Lazarczyk M; Dalard C; Hayder M; Dupre L; Pignolet B; Majewski S; Vuillier F; Favre M; Liblau RS
PLoS One; 2012; 7(6):e39995. PubMed ID: 22761942
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses.
Lazarczyk M; Pons C; Mendoza JA; Cassonnet P; Jacob Y; Favre M
J Exp Med; 2008 Jan; 205(1):35-42. PubMed ID: 18158319
[TBL] [Abstract][Full Text] [Related]
3. EVER2 deficiency is associated with mild T-cell abnormalities.
Crequer A; Picard C; Pedergnana V; Lim A; Zhang SY; Abel L; Majewski S; Casanova JL; Jablonska S; Orth G; Jouanguy E
J Clin Immunol; 2013 Jan; 33(1):14-21. PubMed ID: 22903682
[TBL] [Abstract][Full Text] [Related]
4. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
5. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.
Lazarczyk M; Cassonnet P; Pons C; Jacob Y; Favre M
Microbiol Mol Biol Rev; 2009 Jun; 73(2):348-70. PubMed ID: 19487731
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in
Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
J Virol; 2024 Jun; ():e0017424. PubMed ID: 38869286
[TBL] [Abstract][Full Text] [Related]
7. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
8. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
9. Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
Vuillier F; Gaud G; Guillemot D; Commere PH; Pons C; Favre M
PLoS One; 2014; 9(2):e89479. PubMed ID: 24586810
[TBL] [Abstract][Full Text] [Related]
10. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.
Crequer A; Troeger A; Patin E; Ma CS; Picard C; Pedergnana V; Fieschi C; Lim A; Abhyankar A; Gineau L; Mueller-Fleckenstein I; Schmidt M; Taieb A; Krueger J; Abel L; Tangye SG; Orth G; Williams DA; Casanova JL; Jouanguy E
J Clin Invest; 2012 Sep; 122(9):3239-47. PubMed ID: 22850876
[TBL] [Abstract][Full Text] [Related]
11. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.
de Jong SJ; Créquer A; Matos I; Hum D; Gunasekharan V; Lorenzo L; Jabot-Hanin F; Imahorn E; Arias AA; Vahidnezhad H; Youssefian L; Markle JG; Patin E; D'Amico A; Wang CQF; Full F; Ensser A; Leisner TM; Parise LV; Bouaziz M; Maya NP; Cadena XR; Saka B; Saeidian AH; Aghazadeh N; Zeinali S; Itin P; Krueger JG; Laimins L; Abel L; Fuchs E; Uitto J; Franco JL; Burger B; Orth G; Jouanguy E; Casanova JL
J Exp Med; 2018 Sep; 215(9):2289-2310. PubMed ID: 30068544
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
13. The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.
Kalińska-Bienias A; Kowalewski C; Majewski S
Postepy Dermatol Alergol; 2016 Apr; 33(2):75-80. PubMed ID: 27279814
[TBL] [Abstract][Full Text] [Related]
14. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
[TBL] [Abstract][Full Text] [Related]
15. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
16. Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.
de Jong SJ; Imahorn E; Itin P; Uitto J; Orth G; Jouanguy E; Casanova JL; Burger B
Front Microbiol; 2018; 9():1222. PubMed ID: 29946305
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.
Patel AS; Karagas MR; Pawlita M; Waterboer T; Nelson HH
Int J Cancer; 2008 May; 122(10):2377-9. PubMed ID: 18224692
[TBL] [Abstract][Full Text] [Related]
18. Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis.
Béziat V; Casanova JL; Jouanguy E
Curr Opin Virol; 2021 Dec; 51():9-15. PubMed ID: 34555675
[TBL] [Abstract][Full Text] [Related]
19. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.
Crequer A; Picard C; Patin E; D'Amico A; Abhyankar A; Munzer M; Debré M; Zhang SY; de Saint-Basile G; Fischer A; Abel L; Orth G; Casanova JL; Jouanguy E
PLoS One; 2012; 7(8):e44010. PubMed ID: 22952854
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.
Horton JS; Stokes AJ
Oncoimmunology; 2014 Jan; 3(1):e28288. PubMed ID: 24800179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
